This section of the web-site contains information on medicines, advertising of which is not foreseen by the legislation. Information in this section is intended for reference only, has exclusively scientific and informative character and should not be treated as advertising information for a wide range of people. According to the current legislation, access to this information is granted to medical and pharmaceutical employees. Please confirm that you are a medical or pharmaceutical employee.


Sometimes, when we get ill, we start to be treated, but the recovery does not occur for a long period of time. It’s all the immunity’s fault or, rather, its weakness. Therefore, it would be very difficult to cope with the disease without any extra help. Esberitox* - a German herbal medication can become a good helper in this case.

Esberitox* major task is to improve the body's defenses, to fight viruses and bacteria, accelerate recovery and reduce the incidence of recurrent respiratory illnesses.

Esberitox contains an extract of rhizomes Baptisia, which acts on B-lymphocytes (a type of immune cells) and promotes the formation of antibodies, important immunity soldiers, whose task is to prevent bacteria and viruses growth and neutralize toxic substances generated by these pathogens; dry extract of Echinacea Purpurea and Echinacea Pallida roots that stimulate phagocytosis (active entrapment and destruction of pathogens by special blood cells i.e. phagocytes); and an extract of arborvitae young shoots and leaves, which has an antiviral effect.

Thus, Esberitox acts only via its herbal ingredients. It is well tolerated by children from 4. It does not contain any flavorings, colorants and preservatives.

Esberitox supports immune system in bacterial infections (sinusitis, otitis, pneumonia, tonsillitis, etc.) diagnosed in both RRI and long-term ailing children.

NB! Esberitox intake at the first signs of respiratory diseases helps to reduce their duration by 3 days**, which means that with Esberitox you may recover much faster than usually!

Esberitox – accelerates recovery in respiratory diseases!

No. 40, No.60 Esberitox tablets: produced by Schaper&Brummer GmbH & Co. KG (Germany), Marketing Authorization No. UA/11978/01/01 dd. 25.01.2012.

*Drug advertising. Read instructions carefully and consult a doctor before use. Keep out of the reach of children.

**Ergebnisse einer placebokontrollierten, doppelbinden Studie zur Wirksamkest von Esberitox® bei akuten Atemwegsinfekten. Quelle: Henneicke-von Zepelin, H.-H., et al. // Current Medical Research and Opinion. – 1999. – Vol. 15: 214–227.

Self-medication can be harmful to your health

Schaper & Brummer L03A X21

Accelerates recovery in respiratory diseases

3.2 mg No. 40, No. 60, 20 tablets per blister, 2 or 3 blisters in a carton box

1 tablet contains 3.2 mg of dry extract (4-9:1) of the following mixture:
wild indigo rhizome (Bapticia tinctoria L)
purple coneflower root (Echinacea purpurea Moench)
pale coneflower root (Echinacea pallida Nutt)
thuja fresh shoots and leaves (Thuja occidentalis L.)

Excipients: lactose monohydrate, Macrogol-6000, magnesium stearate, sucrose.

Extraction agent: ethanol 30% (V/V).

Pharmacotherapeutic group: Immunostimulators. ATC code: L03A X21.

Pharmacological properties:
Wild indigo accelerates formation of antibodies. It acts on B-lymphocites (i.e. specific immunity).
Purple and pale coneflower stimulate phagocytosis (i.e. non-specific immunity).
Thuja exerts antiviral effect.

To enhance the body's resistance; as maintenance therapy in combination treatment of viral colds.

Hypersensitivity to the medication active ingredients or to any of its excipients. The medication is not recommended to patients with progressive systemic diseases (tuberculosis and sarcoidosis); autoimmune diseases (collagenosis, multiple sclerosis); immunodeficiency (AIDS, HIV infection); in immunosuppressive states caused by cytostatic agents or immunosuppressants, e.g., after transplantation; hematological diseases (leukemia, agranulocytosis).

Side effects:
Various allergic reactions such as skin rash, swelling of face, rapid breathing, dizziness and blood pressure reduction are possible.

Interactions: Interaction studies were not conducted.

Overdosage: Not reported.

Storage requirements: Keep out of the reach of children and at a temperature not over than 30 °С.

Shelf life: 2 years.

Dispensing method: over the counter

Children aged 4–6 years — 1–2 tablets 3 times a day.

Children aged 7–12 years — 2 tablets 3 times a day.

Adults and children over 12 — 3–6 tablets 3 times a day.

It is recommended to wash down tablets with a plenty of fluids, preferably water, or dissolve in the mouth in the morning, afternoon and evening.

The medication contains lactose and should not be indicated to patients with lactose intolerance. It is not recommended to take medication for more than 2 weeks.

Use in pregnancy and breastfeeding: not applicable.

Use in children: the medication may be indicated to children over 4.

Effects on ability to drive vehicles or use other mechanisms: N/A.


Ask a question

To prevent automated spam submissions leave this field empty.